The pipeline includes 130 GW of large-load opportunities
Research in oral peptide delivery continues to advance across the pharmaceutical industry, but no oral version of retatrutide has been publicly announced by Eli Lilly at the time of writing
The cost of a compromised vial is far less than the risk of injecting a degraded peptide
Storage: Provide clear instructions on refrigeration and handling
However, given that GLP-1 drugs are understood to engage the hypothalamus, the region of the brain that regulates hormones, appetite, and body temperature, the biological plausibility is real
Emerging Trends and Market Dynamics The GLP-1 market is poised for significant growth, with Novo Nordisk and Eli Lilly set to launch new injectables and oral formulations